Study limitation: The study covers a treatment period of 2009–2018, so some PST regimens may not reflect current standard-of-care protocols | ReachRx
Prognostic impact of radiotherapy dose to the axilla in cN + /ypN0 breast cancer after primary systemic therapy and sentinel lymph node biopsy: toward true de-escalation of axillary management
Study limitation reported by the research below: “The study covers a treatment period of 2009–2018, so some PST regimens may not reflect current standard-of-care protocols.”
